View More View Less
  • 1 University of Pécs Second Department of Medicine and Nephrological Center, Faculty of Medicine Pacsirta u. 1 H-7624 Pécs Hungary
  • 2 University of Pécs Department of Laboratory Medicine, Faculty of Medicine Pécs Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

  • Macdougal IC, Cooper A: The inflammatory response and epoetin sensitivity. Nephrol. Dial. Transplant. 17(Suppl 1), 48–52 (2002)

    Cooper A. , 'The inflammatory response and epoetin sensitivity ' (2002 ) 17 Nephrol. Dial. Transplant. : 48 -52.

    • Search Google Scholar
  • Spallone V, Maiello MR, Kurukulasuriya N et al.: Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients? Diabet. Med. 21, 1174–1180 (2004)

    Kurukulasuriya N. , 'Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients? ' (2004 ) 21 Diabet. Med. : 1174 -1180.

    • Search Google Scholar
  • Bosman DR, Osborne CA, Marsden JT, Macdougall IC, Gardner WN, Watkins PJ: Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet. Med. 19, 65–69 (2002)

    Watkins P.J. , 'Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure ' (2002 ) 19 Diabet. Med. : 65 -69.

    • Search Google Scholar
  • Festa A, D’Agostino R Jr, Tracy RP, Haffner SM: Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes. The Insulin Resistance Atherosclerosis Study. Diabetes 51, 1131–1137 (2002)

    Haffner S.M. , 'Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes. The Insulin Resistance Atherosclerosis Study ' (2002 ) 51 Diabetes : 1131 -1137.

    • Search Google Scholar
  • Pickup JC, Chusney GD, Mattock MB: The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute-phase) reaction. Clin. Endocrinol. 52, 107–112 (2000)

    Mattock M.B. , 'The innate immune response and type 2 diabetes: evidence that leptin is associated with a stress-related (acute-phase) reaction ' (2000 ) 52 Clin. Endocrinol. : 107 -112.

    • Search Google Scholar
  • Bilous R: Anaemia — a diabetologist’s dilemma? Acta Diabetol. 39(Suppl 1), 15–19 (2002)

    Bilous R. , 'Anaemia — a diabetologist’s dilemma? ' (2002 ) 39 Acta Diabetol. : 15 -19.

  • Dikow R, Schwenger V, Schömig M, Ritz E: How should we manage anemia in patients with diabetes? Nephrol. Dial. Transplant. 17(Suppl 1), 67–72 (2002)

    Ritz E. , 'How should we manage anemia in patients with diabetes? ' (2002 ) 17 Nephrol. Dial. Transplant. : 67 -72.

    • Search Google Scholar
  • Laville M: New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial. Acta Diabetol. 41(Suppl 1), 18–22 (2004)

    Laville M. , 'New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial ' (2004 ) 41 Acta Diabetol. : 18 -22.

    • Search Google Scholar
  • Salceda S, Caro J: (Hypoxia-inducible factor 1alpha (HIF-1alpha)) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272, 22642–22647 (1997)

    Caro J. , '(Hypoxia-inducible factor 1alpha (HIF-1alpha)) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes ' (1997 ) 272 J. Biol. Chem. : 22642 -22647.

    • Search Google Scholar
  • Droge W: Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47–95 (2002)

    Droge W. , 'Free radicals in the physiological control of cell function ' (2002 ) 82 Physiol. Rev. : 47 -95.

    • Search Google Scholar
  • Alfrey CP, Rice L, Udden MM, Driscoll TB: Neocytolysis: physiological down-regulator of red-cell mass. Lancet 349, 1389–1390 (1997)

    Driscoll T.B. , 'Neocytolysis: physiological down-regulator of red-cell mass ' (1997 ) 349 Lancet : 1389 -1390.

    • Search Google Scholar
  • Rice L, Alfrey CP, Driscoll T, Whitley CE, Hachey DL, Suki W: Neocytolysis contributes to the anemia of renal disease. Am. J. Kid. Dis. 33, 59–62 (1999)

    Suki W. , 'Neocytolysis contributes to the anemia of renal disease ' (1999 ) 33 Am. J. Kid. Dis. : 59 -62.

    • Search Google Scholar
  • Rice L, Ruiz W, Driscoll T et al.: Neocytolysis on descent from altitude: A newly recognized mechanism for the control of red blood cell mass. Ann. Intern. Med. 134, 652–656 (2001)

    Driscoll T. , 'Neocytolysis on descent from altitude: A newly recognized mechanism for the control of red blood cell mass ' (2001 ) 134 Ann. Intern. Med. : 652 -656.

    • Search Google Scholar
  • Colwell JA, Nesto RW: The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care 26, 2181–2188 (2003)

    Nesto R.W. , 'The platelet in diabetes: focus on prevention of ischemic events ' (2003 ) 26 Diabetes Care : 2181 -2188.

    • Search Google Scholar
  • Ritz E: Advances in nephrology: successes and lessons learnt from diabetes mellitus. Nephrol. Dial. Transplant. 16(Suppl 7), 46–50 (2001)

    Ritz E. , 'Advances in nephrology: successes and lessons learnt from diabetes mellitus ' (2001 ) 16 Nephrol. Dial. Transplant. : 46 -50.

    • Search Google Scholar

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Sep 2020 0 0 0
Oct 2020 8 0 0
Nov 2020 2 1 0
Dec 2020 1 0 0
Jan 2021 0 0 0
Feb 2021 0 0 0
Mar 2021 4 0 0